This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Neuspiel, D. R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Neuspiel, D. R.
Related Collections
Right arrow Dermatology
Right arrow Epidemiology

AAP Grand Rounds 4:19-20 (2000)
© 2000 American Academy of Pediatrics

EPIDEMIOLOGY

Sunscreen May Reduce Development of Nevi

Source: Gallagher RP, Rivers JK, Lee TK, et al. Broad-spectrum sunscreen use and the development of new nevi in white children: a randomized controlled trial. JAMA. 2000;283:2955–2960.

The first 20% of the full text of this article appears below.

The presence of acquired melanocytic nevi is a strong risk factor for cutaneous malignant melanoma in white populations. These nevi begin in childhood and are mainly caused by sun exposure. Investigators from British Columbia conducted a randomized trial from 1993–1996 to determine whether use of a broad-spectrum, high-SPF sun-screen attenuates the development of nevi in white children. Children in grades 1 and 4 were randomly assigned to either a treatment group (n=222) that received SPF 30 broad-spectrum sunscreen and instructions to apply it . . . [Full Text of this Article]

Daniel R. Neuspiel, MD, MPH, FAAP
Pediatrics, Epidemiology and Social Medicine, Albert Einstein College of Medicine and Beth Israel Medical Center, New York